PASSIVE HYPERIMMUNE ANTIBODY THERAPY IN THE TREATMENT OF ANTHRAX

Details for Australian Patent Application No. 2002368331 (hide)

Owner HEMACARE CORPORATION

Inventors LEVY, Joshua

Pub. Number AU-A-2002368331

PCT Number PCT/US2002/0304

PCT Pub. Number WO2004/041864

Priority 10/027,478 21.12.01 US

Filing date 25 September 2002

Wipo publication date 7 June 2004

International Classifications

C07K 016/06 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from serum

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61M 001/34 Suction or pumping devices for medical purposes - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

24 June 2004 Complete Application Filed

  Priority application(s): 10/027,478 21.12.01 US

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2002368331

23 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002368332-SHIELDING FOR ELECTRONIC COMPONENTS AND/OR CIRCUITS THAT ARE SENSITIVE TO ELECTROMAGNETIC INTERFERENCE (EMI)

2002368330-1,2,4-thiadiazole compounds and use thereof